cfMethDB: A Comprehensive cfDNA Methylation Data Resource for Cancer Biomarkers
Open Access
- 14 October 2025
- journal article
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 24 (2)
Abstract
Cancer is a major global health threat, and early detection is crucial for improving patient outcomes. DNA methylation in circulating cell-free DNA (cfDNA) has emerged as a promising biomarker for non-invasive cancer diagnosis. However, the integration and utilization of existing cfDNA methylation data have been limited, hindering comprehensive research efforts, particularly in the discovery of cfDNA methylation biomarkers. To address this challenge, we introduce cfMethDB, a comprehensive database dedicated to cfDNA methylation in cancer that encompasses 4828 publicly available datasets. Through standardized analysis, we identified 1,048,770 differentially methylated cytosines (DMCs) as candidate biomarkers across seven cancer types. With cfMethDB, we not only identified known cfDNA methylation biomarkers, but also discovered several genes, such as ZIC4, that could be novel biomarkers. Moreover, cfMethDB offers a suite of user-friendly tools, including biomarker evaluation, pan-cancer search, and end motif analysis. We hope that cfMethDB will serve as a valuable platform for the discovery of novel cancer cfDNA methylation biomarkers and will facilitate cancer research and clinical applications. cfMethDB is publicly available at: https://cfmethdb.hzau.edu.cn/home.Keywords
All Related Versions
This publication has 51 references indexed in Scilit:
- Systematically Evaluating Cell‐Free DNA Fragmentation Patterns for Cancer Diagnosis and Enhanced Cancer Detection via Integrating Multiple Fragmentation PatternsAdvanced Science, 2024
- Ultrafast one‐pass FASTQ data preprocessing, quality control, and deduplication using fastpiMeta, 2023
- Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studiesAnnals of Oncology, 2023
- Evaluation of cell-free DNA approaches for multi-cancer early detectionCancer Cell, 2022
- DNA methylation biomarkers for noninvasive detection of triple‐negative breast cancer using liquid biopsyInternational Journal of Cancer, 2022
- Hypermethylated PCDHGB7 as a universal cancer only marker and its application in early cervical cancer screeningClinical and Translational Medicine, 2021
- Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancerInternational Journal of Cancer, 2020
- Breast cancer early detection: A phased approach to implementationCancer, 2020
- Emerging roles of syndecan 2 in epithelial and mesenchymal cancer progressionIUBMB Life, 2017
- Syndecan-2The International Journal of Biochemistry & Cell Biology, 2006